Involuntary hospitalization under drug impatient treatment
Fetsura I.V.
doi: 10.25557/1682-8313.2024.01.3-7
p. 3-7
European Drug Report 2023. The drug situation in Europe up to 2023 –
an overview and assessment of emerging threats and new developments
European Monitoring Centre for Drug and Drug Addictions
doi: 10.25557/1682-8313.2024.01.8-18
p. 8-18
Treatment and care for people with substance use disorders
who enter the criminal justice system. Part 1
UN Office on Drugs and Crime
doi: 10.25557/1682-8313.2024.01.19-26
p. 19-26
Rifampicin inhibits TLR4 and IL1Β gene expression and enhances SH-SY5Y cell viability
after prolonged ethanol exposure
Airapetov M.I.
doi: 10.25557/1682-8313.2024.01.27-32
p. 27-32
Analysis of the frequency of occupation of haplotypes and pseudohaplotypes of polymorphic variants of the DRD4 and SLC6A3 genes in synthetic drug dependents
Gubina M.A., Babenko V.N., Gubina A.Yu., Solovieva I.G.
doi: 10.25557/1682-8313.2024.01.33-41
p. 33-41
Psychoactive substances as a factor in committing violent crime: current state of the problem
Iskandarov R.R.
doi: 10.25557/1682-8313.2024.01.42-45
p. 42-45
Ethyl glucuronide content in hair as a marker of chronic alcohol intoxication
Razvodovsky Yu.E.
doi: 10.25557/1682-8313.2024.01.46-52
p. 46-52
Digest of English-language Journals of Addictions
doi: 10.25557/1682-8313.2024.01.53-98
p. 53-58
To the 50th Anniversary of Vitaly N. Kholdin
p. 99-100
